TargImmune Therapeutics
Basel
About TargImmune Therapeutics
TargImmune Therapeutics AG is a private Swiss-based biotechnology company focused on drug development using novel targeted onco-immunotherapies. The Company’s principal technology is the CTPIC technology platform that utilizes a non-viral vector to target and destroy cancer cells that over-express certain receptors while simultaneously eliciting an immune response against the cancer cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $19.3M
- Funding stage: M&A
- Last round: Series Unknown (Jul 2021)
- Website: targimmune.com
- Phone: +41 61 225 1926
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/targimmune-therapeutics-88177 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.